|
|
||||||||||||||
|
|
|||||||||||||||
CASE REPORT |
Clinical Biochemistry Unit, Canterbury Health Laboratories, Christchurch, New Zealand
Correspondence to:
Correspondence to:
Dr Florkowski;
chris.florkowski{at}cdhb.govt.nz
ABSTRACT
A woman was screened for diabetes using glycated haemoglobin (HbA1c). Vastly different results were obtained by high performance liquid chromatography (45%), immunoassay (2.9%), and affinity chromatography (4.2%) compared with the non-diabetic range of less than 6.4%. Mass spectral studies confirmed the presence a haemoglobin variant, haemoglobin Marseille-Long Island which had confounded interpretation by all methods.
Keywords: glycated haemoglobin; HbA1c; haemoglobin variants
Abbreviations: HbA1c, glycated haemoglobin; HPLC, high performance liquid chromatography
This article has been cited by other articles:
![]() |
M. Bakhti, M. Habibi-Rezaei, A.A. Moosavi-Movahedi, and M.R. Khazaei Consequential Alterations in Haemoglobin Structure upon Glycation with Fructose: Prevention by Acetylsalicylic Acid J. Biochem., June 1, 2007; 141(6): 827 - 833. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |